Jane O'Donnell
Has grant
Senior Research Fellow
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Health Research Council NZ Grant : Delivery of Respiratory Support in the ED
Open Date: 2023-01-01
Close Date: 2023-01-01
Grant: Close
Fisher & Paykel Hlth Care Ltd Unrestricted Grant: Respiratory Support in ED
Open Date: 2020-01-01
Close Date: 2023-01-01
Grant: Close
Ako Aotearoa Grant : Post Graduate Study Grant - Design and evaluation of a new web-based educational tool for systematic review authoring skills
Open Date: 2011-01-01
Close Date: 2011-12-01
Grant: Close
Smith & Nephew Grant: Post Graduate Study Grant
Open Date: 2010-01-01
Close Date: 2010-01-01
Articles (8)
Year:
2026
Year:
2026
Year:
2025
Background An estimated 20% of emergency department (ED) patients require respiratory support (RS). Evidence suggests that nasal high flow (NHF) reduces RS need. Aims This review compared NHF to conventional oxygen therapy (COT) or noninvasive ventilation (NIV) in adult ED patients. Method The systematic review (SR) and meta‐analysis (MA) methods reflect the Cochrane Collaboration methodology. Six databases were searched for randomized controlled trials (RCTs) comparing NHF to COT or NIV use in the ED. Three summary estimates were reported: (1) need to escalate care, (2) mortality, and (3) adverse events (AEs). Results This SR and MA included 18 RCTs ( n = 1874 participants). Two of the five MA conclusions were statistically significant. Compared with COT, NHF reduced the risk of escalation by 45% (RR 0.55; 95% CI [0.33, 0.92], p = .02, NNT = 32); however, no statistically significant differences in risk of mortality (RR 1.02; 95% CI [0.68, 1.54]; p = .91) and AE (RR 0.98; 95% CI [0.61, 1.59]; p = .94) outcomes were found. Compared with NIV, NHF increased the risk of escalation by 60% (RR 1.60; 95% CI [1.10, 2.33]; p = .01); mortality risk was not statistically significant (RR 1.23, 95% CI [0.78, 1.95]; p = .37). Linking Evidence to Action Evidence‐based decision‐making regarding RS in the ED is challenging. ED clinicians have at times had to rely on non‐ED evidence to support their practice. Compared with COT, NHF was seen to be superior and reduced the risk of escalation. Conversely, for this same outcome, NIV was superior to NHF. However, substantial clinical heterogeneity was seen in the NIV delivered. Research considering NHF versus NIV is needed. COVID‐19 has exposed the research gaps and slowed the progress of ED research.
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Collaborators (6)
Q. Sue Huang
Institute of Environmental Sciences and Research
Jane Key
Senior Lecturer
Massey University - Albany Campus
Nikki Turner
Professor
University of Auckland
Peter McIntyre
Professor
University of Otago
Janine Paynter
University of Auckland
Elissa McDonald
-
Make your next move.
Prepare your application
Review drafts before you send them.